Cleveland BioLabs, Inc. (NASDAQ: CBLI) stock was tossed up almost 30% to $3.7 in the late hours on Friday after the reports that in connection with the merger of CBLI with Cytocom, the Lifshitz Law Firm, P.C. is investigating possible breaches of fiduciary duties. CBLI investors who wish to learn more about our investigation should complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at firstname.lastname@example.org.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free